ICOS and neoplasm: The flow cytometry analysis of resting and CD3+/CD28+-activated and SN-treated CD4+ T cells showed before that in these CD4+ T cells tumor, the SN inhibited the activation-induced expression of CD69, ICOS, and CD25 proteins (see Figure 6A,B in reference [19]).